Citation Impact
Citing Papers
Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
1992
Improved Survival Among Patients With Eisenmenger Syndrome Receiving Advanced Therapy for Pulmonary Arterial Hypertension
2009
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
2002 Standout
The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1
1994 StandoutNature
Angiographic demonstration of a common link between unstable angina pectoris and non-Q wave acute myocardial infarction
1988
Mechanisms of arterial thrombosis in nonparallel streamlines: platelet thrombi grow on the apex of stenotic severely injured vessel wall. Experimental study in the pig model.
1989
Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty
1989
Intracranial Aneurysms in Patients With Coarctation of the Aorta: A Prospective Magnetic Resonance Angiographic Study of 100 Patients
2003
Primary Pulmonary Hypertension
2000
Medical Therapy For Pulmonary Arterial Hypertension
2004
Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes
1989
Minimal Sulfated Carbohydrates for Recognition by L-selectin and the MECA-79 Antibody
2000 StandoutNobel
Long term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension
1998
Circadian variation in the incidence of sudden cardiac death in the framingham heart study population
1987
Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis
2002
Treatment of Pulmonary Arterial Hypertension
2004 Standout
Neointimal Formation After Balloon-Induced Vascular Injury in Yucatan Minipigs is Reduced by Oral Rapamycin
1999
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
1996 Standout
Prospects for Cardiovascular Research
2001 StandoutNobel
Percutaneous Interventions on Severe Coarctation of the Aorta: A 21-Year Experience
2005
Restenosis after coronary angioplasty: The paradox of increased lumen diameter and restenosis
1992
Toward the quiescent coronary plaque
1993
Embolic strokes of undetermined source: the case for a new clinical construct
2014 Standout
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
1995 Standout
Rare diseases bullet 5: Primary pulmonary hypertension
1999
Angioscopy in variant angina: coronary artery spasm and intimal injury
1993
Primary pulmonary hypertension: Current therapy
2002
Pulmonary hypertension: Newer concepts in diagnosis and management
1997
A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease
1994 Standout
A perspective on the potential problems with aspirin as an antithrombotic agent: a comparison of studies in an animal model with clinical trials
1999
Clinical classification of pulmonary hypertension
2004 Standout
Survival with first-line bosentan in patients with primary pulmonary hypertension
2005
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
1995 Standout
The Acute Administration of Vasodilators in Primary Pulmonary Hypertension: Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension
1989
Primary Pulmonary Hypertension
1997 Standout
Pulmonary Arterial Hypertension
2006
Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
1992 StandoutNature
A Prospective Natural-History Study of Coronary Atherosclerosis
2011 Standout
Pathophysiology of acute coronary syndromes
1991
Primary pulmonary hypertension
2003
Surgical and Interventional Therapies for Pulmonary Arterial Hypertension
2005
Survival in Patients with Primary Pulmonary Hypertension
1991 Standout
Restenosis after coronary angioplasty: A multilvariate statistical model to relate lesion and procedure variables to restenosis
1991
Effects of the Dual Endothelin Receptor Antagonist Bosentan in Patients With Pulmonary Arterial Hypertension
2003
Treatment of Primary Pulmonary Hypertension with Continuous Intravenous Prostacyclin (Epoprostenol)
1990
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
2004
An Imbalance between the Excretion of Thromboxane and Prostacyclin Metabolites in Pulmonary Hypertension
1992
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Synergistic action of severe wall injury and shear forces on thrombus formation in arterial stenosis: Definition of a thrombotic shear rate threshold
1994
Platelet Activation and Atherothrombosis
2007 Standout
Pathobiology of pulmonary arterial hypertension
2002
Fibrinogen, t-PA, and PAI-1 plasma levels in patients with pulmonary hypertension.
1994
Fibrin and Fibrinogen-Related Antigens in Patients with Stable and Unstable Coronary Artery Disease
1987
Congenital Heart Disease Associated Pulmonary Arterial Hypertension
2007
Heterogeneity of Pathologic Lesions in Familial Primary Pulmonary Hypertension
1988
Pulmonary Hypertension Associated with Long-standing Thrombocytosis
1991
The Use of Aspirin in Ischemic Heart Disease
1992
Protective and Damaging Effects of Stress Mediators
1998 Standout
Doppler echocardiographic index for assessment of global right ventricular function
1996
Outcomes in patients with pulmonary hypertension undergoing percutaneous atrial septal defect closure
2007
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Bosentan Therapy for Pulmonary Arterial Hypertension
2002 Standout
Prospects for the use of antagonists to the platelet glycoprotein IIb/ IIIa receptor to prevent postangioplasty restenosis and thrombosis
1991
Pulmonary arterial hypertension in congenital heart disease: An epidemiologic perspective from a Dutch registry
2006
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Hypertensive Pulmonary Vascular Disease in Adults with Secundum or Sinus Venosus Atrial Septal Defect
2005
Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension
2002
Regulatory Functions of the Vascular Endothelium
1990 StandoutNobel
Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferation
1990
Surgical Management of Unresolved Pulmonary Embolism
1995
Atherosclerosis — An Inflammatory Disease
1999 Standout
Angiographic progression of coronary artery disease and the development of myocardial infarction
1988
CLINICAL CLASSIFICATION OF PULMONARY HYPERTERNSION
2001
Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age A prospective follow-up study of 21–33 years
2003
Long-term follow-up of patients after coarctation of the aorta repair
2002
Retroviral vectors displaying functional antibody fragments
1993 StandoutNobel
Coarctation Long-term Assessment (COALA): Significance of arterial hypertension in a cohort of 404 patients up to 27 years after surgical repair of isolated coarctation of the aorta, even in the absence of restenosis and prosthetic material
2007
Triggering and hourly variation of onset of arterial thrombosis
1992
Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
1999 StandoutNobel
Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension.
1995
Re-Stenosis after Successful Coronary Angioplasty
1988
Prognosis of Pulmonary Arterial Hypertension*
2004
The new clinical trials on pharmacological treatment in pulmonary arterial hypertension
2002
Value of a Doppler-Derived Index Combining Systolic and Diastolic Time Intervals in Predicting Outcome in Primary Pulmonary Hypertension
1998
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Pulmonary thrombosis in adults with Eisenmenger syndrome
2003
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
1992 Standout
Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension
2004
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
1997 Standout
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
2000 Standout
Percutaneous Transluminal Coronary Angioplasty
1994
Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary Angioplasty
1988
Platelet aggregation, coronary artery disease progression and future coronary events
1994
Severe pulmonary hypertension without right ventricular failure: the unique hearts of patients with Eisenmenger syndrome
2002
The Effect of Anticoagulant Therapy in Primary and Anorectic Drug-Induced Pulmonary Hypertension
1997
Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil
2006
Coarctation of the aorta: outcome of pregnancy
2001
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
1998 Standout
Selective Antagonism of the ETA Receptor Reduces Neointimal Hyperplasia After Balloon-Induced Vascular Injury in Pigs
1997
Introduction
2004
Coexistent pulmonary and portal hypertension: Morphologic and clinical features
1987
Perioperative Normothermia to Reduce the Incidence of Surgical-Wound Infection and Shorten Hospitalization
1996 Standout
Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers
2006
The Catecholamine, Cortisol, and Hemodynamic Responses to Mild Perioperative Hypothermia
1995
The Adult With Congenital Heart Disease
2005
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
RISK FACTORS FOR PULMONARY ARTERIAL HYPERTENSION
2001
Anti-adhesive therapeutics: A new class of anti-inflammatory agents
1994
Effects of thrombosis on vascular tone in rat mesenteric arteries with endothelium in vivo.
1990
Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty. A quantitative arteriographic analysis.
1988
Genetic Models of Human Vascular Disease
1995 StandoutNobel
Tissue Engineering
1993 StandoutScience
Effect of Thromboxane A 2 Blockade on Clinical Outcome and Restenosis After Successful Coronary Angioplasty
1995
Guidelines for the early management of patients with acute myocardial infarction
1990
Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension.
1989
Pulmonary Vascular Disease in Adults With Congenital Heart Disease
2007
Pulmonary Arterial Hypertension in Patients With Transcatheter Closure of Secundum Atrial Septal Defects
2009
Blade Balloon Atrial Septostomy in Patients With Severe Primary Pulmonary Hypertension
1995
Recombinant Gene Expression in Vivo Within Endothelial Cells of the Arterial Wall
1989 Science
Long-Term Results of Pediatric Cardiac Surgery in Finland: Education, Employment, Marital Status, and Parenthood
2003
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
Long-Term Prostacyclin for Pulmonary Hypertension With Associated Congenital Heart Defects
1999
Risk of stroke in adults with cyanotic congenital heart disease.
1993
Targeting G βγ signaling in arterial vascular smooth muscle proliferation: A novel strategy to limit restenosis
1999 StandoutNobel
Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty.
1987
Pulmonary Arterial Hypertension
2006
Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction.
1988
Compassionate Use of Continuous Prostacyclin in the Management of Secondary Pulmonary Hypertension: A Case Series
1999
Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group.
1989
Morphology of the endothelium over atherosclerotic plaques in human coronary arteries.
1988
Employment and insurance for young adults with congenital heart disease.
1993
Monitoring the effect of heparin by measurement of activated clotting time during and after percutaneous transluminal coronary angioplasty.
1990
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Sudden cardiac death. Support for a role of triggering in causation.
1993
Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension.
1993
Vasodilator Therapy for Primary Pulmonary Hypertension in Children
1999
Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm?
1990
Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization
1997 Standout
Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension.
1994
Endothelium-derived relaxing factor and coronary vasospasm.
1989
Effect of Inhaled Iloprost Plus Oral Sildenafil in Patients With Primary Pulmonary Hypertension
2001
Survival in primary pulmonary hypertension. Validation of a prognostic equation.
1994
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
Outcomes in Children With Idiopathic Pulmonary Arterial Hypertension
2004
Roles of thrombin and platelet membrane glycoprotein IIb/IIIa in platelet-subendothelial deposition after angioplasty in an ex vivo whole artery model.
1991
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Survival in Primary Pulmonary Hypertension
2002
Coronary Plaque Disruption
1995 Standout
Site-Specific Gene Expression in Vivo by Direct Gene Transfer into the Arterial Wall
1990 Science
Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin).
1987
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Primary Pulmonary Hypertension: A Histopathologic Study of 80 Cases
1985
Left Ventricular Outflow Obstruction
2006
Primary Pulmonary Hypertension
1993
Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
1994 Standout
Primary Pulmonary Hypertension: Radiographic and Scintigraphic Patterns of Histologic Subtypes
1986
Imaging of vascular injury with 99mTc-labeled monoclonal antiplatelet antibody S12. Preliminary experience in human percutaneous transluminal angioplasty.
1992
Primary Pulmonary Hypertension
1987
Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology.
1994
Gene Therapy for Vascular Smooth Muscle Cell Proliferation After Arterial Injury
1994 Science
Suppression of eicosanoid biosynthesis during coronary angioplasty by fish oil and aspirin.
1991
Platelet thrombus formation on collagen type I. A model of deep vessel injury. Influence of blood rheology, von Willebrand factor, and blood coagulation.
1988
Atrial Septal Defects in the Adult
2006
Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study (CARPORT).
1991
Intracoronary thrombus formation causes focal vasoconstriction of epicardial arteries in patients with coronary artery disease.
1991
Works of Peter M. Steele being referenced
Antithrombotic therapy for deep arterial injury by angioplasty. Efficacy of common platelet inhibition compared with thrombin inhibition in pigs.
1991
The role of adrenal medullary catecholamine release in the response to a cold pressor test
1983
Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo.
1987
Primary pulmonary hypertension: natural history and the importance of thrombosis.
1984
Coarctation of the aorta. Long-term follow-up and prediction of outcome after surgical correction.
1989
Isolated atrial septal defect with pulmonary vascular obstructive disease--long-term follow-up and prediction of outcome after surgical correction.
1987
Systemic Embolism in Chronic Left Ventricular Aneurysm: Incidence and the Role of Anticoagulation
1985
Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death
1985
Deep arterial injury during experimental angioplasty: Relation to a positive indium-111-labeled platelet scintigram, quantitative platelet deposition and mural thrombosis
1986
Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model.
1985